It's now possible to diagnose strokes from scans sent to a smart-phone, using a newly developed Candian app. Researchers found that the sensitivity and specificity of detecting intraparenchymal hemorrhage were 100 percent for the iOS device.
If radiologists need another reason to justify their iPhone, it just arrived. It's now possible to diagnose strokes from scans sent to a smart-phone, using a newly developed Candian app, with positive implications for teleradiology and rural communities.
A retrospective study published May 6th in the Journal of Medical Internet Research, had two neuroradiologists reading 120 recent consecutive nonconrast CT (NCCT) brain scans, plus 70 CT angiograms (CTA) head scans from the Calgary Stroke Program database. One reader used a diagnostic workstation, the other used an iPhone or iPod Touch (iOS device). Readers looked at NCCT scans for early signs of infarction, including early parenchymal ischemic changes and dense vessel sign, excluding acute intraparenchymal hemorrhage and stroke mimics. They evaluated CTA scans for any intracranial vessel occlusion, then compared the diagnoses from both platforms.
Researchers found that the sensitivity and specificity of detecting intraparenchymal hemorrhage were 100 percent for the iOS device. As for the sensitivity, specificity and accuracy of detecting acute parenchymal ischemic change, those figures were 94.1 percent, 100 percent and 98.09 percent respectively for the first reader, and 97.05 percent, 100 percent and 99.04 percent for the second reader. In detecting vessel occlusion on CTA, the sensitivity, specificity, and accuracy were 94.4 percent, 100 percent and 98.46 percent for both readers. There was also no significant difference in the amount of time it took them to read the images on the iOS compared to the workstation.
The iOS application can view both 2-D and 3-D images, and can be manipulated by the user, with results in seconds. No patient data is stored on the iOS device, rather it’s stored on a remote, secure server. This study was designed by Mayank Goyal, MD, of the Hotchkiss Brain Institute (HBI), and the iPhone software technology was originally developed by Ross Mitchell, PhD, and others at HBI. It was then enhanced and commercialized by Calgary Scientific Inc.
The app is ResolutionMD Mobile, which can also be used on Android smart-phones and iPads, as well as web-based browsers. The computing work is done on a server, then streaming the images to the smart-phone in real time. Health Canada approved the app in April 2010, so doctors there can make primary diagnoses using it. It’s since reportedly been licensed to medical imaging companies and 50,000 hospitals, so doctors should have access to it within the next two years.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.